Hims & Hers Health, Inc. · Q4 2024
ReportedFeb 24, 2025
Period endedDec 31, 2024
Rule of 40+108
The quarter in short
Revenue $481M, up 95.1% year over year and 19.8% on the quarter. EPS $0.11, down 65.6% on the quarter. Free cash flow $62M, up 363.4% year over year and down 24.5% on the quarter. Rule of 40 score +108.
Reported this quarter
Revenue
$481M
QoQ +19.8%
YoY +95.1%
EPS
$0.11
QoQ −65.6%
YoY +1000.0%
Free Cash Flow
$62M
QoQ −24.5%
YoY +363.4%
Gross Margin
76.8%
QoQ −2.3 pp
YoY −5.9 pp
FCF Margin
12.9%
QoQ −7.5 pp
YoY +7.4 pp
P/E Ratio
44.8
QoQ +7.0%
YoY —
Each tile opens the full quarterly series. Download the numbers as CSV or JSON.
Coverage around this release
Sources & downloads
Company
Published by the company on the day of the release.
HTML
Earnings press release
Investor relations announcement
SEC filings
Filed with the SEC under CIK 1773751.
HTML
8-K results announcement
Filed Feb 24, 2025
HTM
Press release (EX-99.1)
Exhibit 99.1 to the 8-K
289 KB
HTM
Exhibit EX-99.2
Exhibit 99.2 to the 8-K
81 KB
HTML
Filing index
Every document in the 8-K submission
TXT
Complete submission
Raw archival text of the whole filing
HTML
10-K annual report
Period ended Dec 31, 2024, filed Feb 24, 2025
ZIP
XBRL data bundle
Structured financial statements from the 10-K
JSON
Company facts (XBRL)
Every figure HIMS has reported to the SEC
R40 data
The numbers shown on this page, as we hold them.
CSV
This quarter (CSV)
Reported metrics for Q4 2024, spreadsheet-ready
JSON
This quarter (JSON)
Metrics, dates and matched filings